A carregar...
Targeting IL-4 for the Treatment of Atopic Dermatitis
Atopic dermatitis (AD) is an immune-mediated inflammatory skin disease characterized by a predominant type 2 immune response. Type 2 immunity is driven by multiple cytokines, including interleukin (IL)‑4 and IL-13 that are considered central to AD pathogenesis and key therapeutic targets. The dual i...
Na minha lista:
| Publicado no: | Immunotargets Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7532907/ https://ncbi.nlm.nih.gov/pubmed/33062619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S260370 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|